REITs, BDCs, and Alternative Investments Explained: Illiquid Products, Valuation Issues, and Sales-Practice Risk
Worried you were sold a REIT, BDC, or other alternative investment that seemed safe on your statement but is hard to value or sell when you need the money? This guide explains how REITs and BDCs work, why illiquid products often have valuation issues, and where sales-practice risk can lead to FINRA arbitration disputes. ReferU.AI can help you find an attorney with relevant experience to review your situation and next steps.
Why can REITs and BDCs look steady on paper while hiding serious sales-practice risk?
The danger is not just market loss, it is illiquidity, opaque valuation, and how the product was sold.
See what makes these Alternative Investments disputes different before account statements tell the full story.
For more information, visit https://blog.referu.ai/legal-information-by-practice-area/securities-arbitration-finra-disputes/reits-bdcs-alternative-investments.
Need a Securities Arbitration attorney? ReferU.AI: AI + 6B court records = proven attorneys for you. Experienced with your case, your opposing counsel, your judge, your venue.
#LegalAdvice #LegalHelp #SecuritiesArbitration #REITs #AlternativeInvestments
This post is for informational purposes only. ReferU.AI is not a law firm and does not provide legal advice.
Flat vector illustration of REITs and BDCs as alternative investments, showing illiquidity, valuation issues, and sales-practice risk with real estate, private credit, and portfolio review symbols.
REITs, BDCs, and Alternative Investments Explained: Illiquid Products, Valuation Issues, and Sales-Practice Risk
Alternative investments often show up in brokerage accounts with reassuring labels: income, real estate exposure, private credit, diversification, or access to opportunities outside the stock market. For many investors, that sales pitch can sound reasonable. But products like non-traded REITs, BDCs, private placements, and other illiquid securities can raise a very different set of risks than ordinary publicly traded stocks or mutual funds.
In general terms, these products are often harder to value, harder to sell, and more dependent on issuer-provided information than exchange-traded investments. That combination can create problems not only for investors, but also for brokerage firms and financial professionals responsible for recommending them. FINRA has repeatedly highlighted concerns involving liquidity, transparency, valuation, concentration, due diligence, and sales practices in this area, while the SEC’s Regulation Best Interest framework applies to recommendations made to retail customers. FINRA Rule 2111, SEC Reg BI guidance, FINRA private placement guidance
If you are trying to understand how these products work — and why investor claims involving them often look different from ordinary market-loss disputes — this post walks through the basics. In this post you’ll learn what REITs and BDCs are, why illiquidity matters so much, how valuation problems can distort account statements, and where sales-practice risk often enters the picture. If you want the larger arbitration framework, it can help to start with this overview of how investor disputes with brokerage firms are often handled.
💡
Scroll to the bottom for every post in this series.
What Are REITs, BDCs, And Alternative Investments?
A REIT, or real estate investment trust, is a company that owns, finances, or operates real estate-related assets. Some REITs trade on national exchanges. Others do not. The non-traded or unlisted versions tend to be where many investor complaints arise because they are generally less liquid and less transparent than exchange-traded securities. FINRA has long warned that non-traded REITs can involve limited liquidity, unclear valuation, heavy fees, conflicts of interest, and distributions that may come from sources other than operating income. FINRA 2011 Priorities Letter, FINRA 2012 Priorities Letter
A BDC, or business development company, is a type of closed-end investment company that generally invests in smaller or middle-market businesses, often through loans or other less-liquid instruments. SEC materials and BDC offering disclosures commonly note that these portfolios can involve private or thinly traded companies, limited public information, management risk, and illiquid holdings that may be difficult to value. SEC BDC-related disclosure example, SEC BDC-related risk disclosure example
Alternative investments is the broader umbrella term. Depending on the context, that phrase can include non-traded REITs, BDCs, private placements, direct participation programs, interval funds, hedge-fund-like products, structured products, and other investments that do not behave like plain-vanilla publicly traded securities. FINRA’s investor education materials note that these products can be complex and can create overconcentration concerns if they occupy too much of an account. FINRA alternative and emerging products overview
Why Do Illiquid Products Create Different Risks?
The simplest distinction is this: with an exchange-traded stock, there is usually a visible market price and a functioning market where shares can be sold quickly. With many alternative investments, that is not true.
For non-traded REITs, FINRA has described liquidity constraints plainly: the investment may not become liquid unless the issuer eventually lists shares, liquidates assets, or offers limited redemption opportunities, and those redemption opportunities may be restricted, discounted, or terminated. In one FINRA disciplinary decision, the record noted that liquidity events may not occur for more than ten years after purchase, if they happen at all. FINRA disciplinary decision discussing non-traded REIT risks
That matters because illiquidity can change the entire investor experience:
Access To Money Can Be Limited
An investor may believe an account balance is available if needed for emergencies, retirement distributions, or changing market conditions. But many alternative products have no ready secondary market, and issuer redemption programs can be narrow, suspended, or priced below the carrying value shown on the statement. FINRA Rule 2231 requires customer statements for unlisted DPPs and REITs to disclose that these securities are generally illiquid and that any sale price may be lower than the estimated per-share value shown. FINRA Rule 2231
Price Discovery Is Weak
With a public stock, investors can usually see where buyers and sellers are meeting in real time. With illiquid alternatives, there may be no meaningful daily market price at all. That can make it harder to tell whether the position is stable, deteriorating, or carrying substantial embedded loss.
Losses Can Surface Late
One reason these cases feel so confusing is that trouble may not become obvious immediately. An investor might receive statements showing a steady estimated value for months or years, even while the underlying assets or business prospects are weakening. By the time the issuer cuts distributions, suspends redemptions, revises value downward, or announces distress, the account may look very different from what the investor thought he or she owned.
Why Are Valuation Issues So Common In These Products?
Valuation is one of the biggest fault lines in alternative-investment disputes.
For unlisted REITs and DPPs, FINRA’s customer statement rule requires firms to report a per-share estimated value using specified methods and disclosures. Those values may be based on a “net investment” methodology early on, or an appraised value derived from annual asset-and-liability valuations with material assistance or confirmation from a third-party valuation expert or service. Even then, the rule also requires disclosure that the securities are not exchange-listed, are generally illiquid, and may sell for less than the reported estimate. FINRA Rule 2231
That framework helps with transparency, but it does not eliminate the underlying problem: an estimated value is not the same thing as a real-time market price.
Statement Values May Look More Certain Than They Really Are
Many investors understandably treat the number on a brokerage statement as a close approximation of what an investment is worth. With illiquid alternatives, that assumption can be misleading. The number may depend on issuer data, appraisal assumptions, lagging information, or valuation methods that do not reflect what an investor could actually obtain in an arms-length sale.
A product may continue paying distributions even while the underlying investment is under pressure. FINRA has warned that some products may fund distributions with borrowed money, newly raised capital, or returns of investor principal rather than operating profits. When that happens, the cash flow to the investor can create the impression that the investment is healthy even though the underlying economics are weaker than expected. FINRA 2012 Priorities Letter, FINRA Rule 2231 disclosure language
BDC Valuation Can Be Complicated Too
BDCs often hold loans or equity interests in smaller, less-liquid businesses. Those holdings may not trade frequently, and public information may be limited. That can make fair-value estimates more judgment-dependent than a quoted exchange price. SEC-related BDC disclosures commonly emphasize that little public information may exist for portfolio companies and that illiquidity can affect fair value and net asset value calculations. SEC BDC-related disclosure example, SEC BDC-related risk disclosure example
Where Does Sales-Practice Risk Enter The Picture?
Sales-practice risk usually refers to problems in the way an investment was recommended, described, supervised, or placed in an account. With alternative investments, these issues often become central because the products are complex and the investor is relying heavily on the broker’s explanation.
Suitability And Investor Profile Concerns
FINRA Rule 2111 says a recommendation must be based on the customer’s investment profile, including age, financial situation, investment objectives, time horizon, liquidity needs, and risk tolerance. FINRA Rule 2111
That can be especially important with illiquid products. A recommendation that may look acceptable for one investor can look very different for someone who is retired, relies on account access for living expenses, has limited tolerance for principal impairment, or lacks experience with non-traded investments. The SEC’s staff guidance under Regulation Best Interest similarly explains that a firm generally cannot form a reasonable belief that a recommendation is in a retail investor’s best interest without sufficient investor information. SEC Staff Bulletin on Standards of Conduct, SEC Reg BI FAQ
Alternative investments may be marketed as diversifiers, but concentration risk can still become severe if too much of an account ends up in one issuer, one strategy, one product category, or one illiquid sleeve. FINRA’s investor guidance explicitly warns against overconcentration in alternative and emerging products. FINRA alternative and emerging products overview
In an arbitration setting, concentration questions often focus less on whether a product was risky in the abstract and more on how much of the investor’s net worth or portfolio was tied up in illiquid, hard-to-value holdings at the same time.
Due Diligence And Product Understanding
FINRA has repeatedly said firms offering private placements and other non-conventional investments are expected to conduct a reasonable investigation, understand the product’s features and risks, and provide balanced disclosure of risks and rewards. FINRA private placements guidance, FINRA Notice to Members 03-71
That matters because some alternative-investment disputes are not only about the investor’s profile. They also involve whether the firm adequately investigated the issuer, understood leverage, redemption limitations, fee layers, conflicts, or the basis for projected income.
Incomplete Or Overly Simplified Explanations
A recurring issue in these cases is the gap between how the product was described and how it functioned in practice. Investors may recall hearing phrases like “income-producing,” “stable,” “less volatile than the market,” or “good for diversification,” while the offering documents described substantial risks tied to illiquidity, leverage, conflicts, valuation uncertainty, and possible loss of principal. FINRA has repeatedly identified concerns about marketing materials that omit material risk disclosures or fail to provide a sound basis for evaluating a product. FINRA 2011 Priorities Letter, FINRA Notice to Members 03-71
Why Do These Products Lead To Arbitration Claims?
Many investor disputes involving REITs, BDCs, and similar products proceed through FINRA arbitration rather than court because brokerage account agreements often contain arbitration clauses. FINRA’s dispute resolution statistics show that customer arbitration filings remain an active part of the forum; for 2025, FINRA reported 1,643 customer case filings and an overall turnaround time of 13.4 months across closed cases. FINRA 2025 dispute resolution statistics
The claims themselves often focus on one or more of the following themes:
The Investment Did Not Match The Account
This can involve allegations that the product’s illiquidity, complexity, risk profile, or concentration level did not align with the investor’s objectives, liquidity needs, or tolerance for loss.
The Risks Were Not Fully Presented
Some cases center on alleged omissions or half-truths about redemption restrictions, valuation uncertainty, source of distributions, leverage, issuer distress, or how difficult it might be to exit the position.
The Reported Value Did Not Reflect Real-World Exit Value
In some disputes, the investor’s statement value remained comparatively stable while any available secondary-market bids, tender offers, or later issuer marks suggested materially lower realizable value.
The Firm’s Supervision Or Due Diligence Was Inadequate
These claims may examine what the firm knew, what investigation was performed, what red flags existed, how the recommendation was approved, and whether supervision of concentrated sales practices was sufficient.
What Facts Often Matter Most In A Potential Investor Claim?
Every case turns on its own record, but certain categories of evidence often carry significant weight.
Account Forms And Investment Objectives
New account forms, updates to objectives, risk-tolerance entries, and notes about liquidity needs can become important because they show what the broker and firm recorded about the customer at the time of recommendation.
Offering Documents And Sales Materials
Prospectuses, private placement memoranda, subscription documents, slide decks, emails, and notes from meetings can help reconstruct what was disclosed, what was emphasized, and what may have been left unsaid.
Statements Showing Concentration And Reported Value
Quarterly account statements may help show how much of the portfolio was allocated to illiquid products and how the position was carried over time. In unlisted REIT and DPP cases, those statements may also reveal the estimated value methodology and required liquidity disclosures. FINRA Rule 2231
Redemption History, Tender Offers, And Liquidity Events
Evidence that redemptions were suspended, limited, discounted, or unavailable may help explain why the investor could not access funds at the time they were needed.
Communications About Income Or Safety
Emails, texts, handwritten notes, or meeting summaries sometimes become central where the dispute involves whether a product was framed as stable income, principal preservation, or a conservative allocation tool.
Not every recommendation of a REIT or BDC is problematic. Some products are exchange-traded, some investors are fully aware of the structure, and some allocations are limited and deliberate. The legal dispute usually turns less on the product label and more on the surrounding facts:
Was the product traded on an exchange or unlisted?
How much of the account was allocated to illiquid alternatives?
What did the investor say about liquidity needs and time horizon?
How were distributions described?
What did the statements show, and how were those values derived?
What due diligence did the firm perform?
How did the recommendation compare with the customer’s broader financial picture?
That is why broad generalizations can be misleading. A non-traded REIT in a modest allocation for an investor who understood the lockup is a very different scenario from a large concentration in illiquid products sold to a retiree who expected ready access to principal.
The Bottom Line
REITs, BDCs, and other alternative investments are often presented as a way to diversify beyond ordinary stocks and bonds. In general terms, the real legal friction tends to arise when illiquidity, valuation uncertainty, and sales-practice issues collide. A product can look steady on paper while being difficult to sell, hard to value, expensive to own, and mismatched to the investor’s actual circumstances.
For investors, the core questions are often straightforward: What exactly was sold, how liquid was it really, how reliable was the reported value, and did the recommendation fit the account it went into? When those questions point in different directions, arbitration claims often follow.
Visit ReferU.AI to get matched with an attorney who has demonstrable experience in cases like yours — for free.